Protalix BioTherapeutics (PLX) Hit as EMA CHMP Denies MAA for Taliglucerase Alfa

June 22, 2012 8:44 AM EDT Send to a Friend
Get Alerts PLX Hot Sheet
Trade PLX Now!
Join SI Premium – FREE
Protalix BioTherapeutics (AMEX: PLX) shares are lower following news taliglucerase alfa did not get marketing approval from the EMA CHMP.

Shares are down about 14 percent ahead of the bell Friday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

FDA, Insiders' Blog, Momentum Movers

Add Your Comment